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Abstract. Thyrotoxicosis (TT) is associated with an increase in both total and 
cardiovascular mortality. One of the main thyrotoxicosis risks is Atrial Fibrilla-
tion (AF). Right AF predicts help medical personal prescribe the correct medica-
ments and correct surgical or radioiodine therapy. The main goal of this study is 
creating a method for practical treatment and diagnostic AF. This study proposes 
a new method for assessing the risk of occurrence atrial fibrillation for patients 
with TT. This method considers both the features of the complication and the 
specifics of the chronic disease. A model is created based on case histories of 
patients with thyrotoxicosis. We used Machine Learning methods for creating 
several models. Each model has advantages and disadvantages depending on the 
diagnostic and medical purposes. The resulting models show high results in the 
different metrics of the prediction of AF. These models interpreted and simple 
for use. Therefore, models can be used as part of the support and decision-making 
system (DSS) by medical specialists in the treatment and diagnostic of AF. 
Keywords: Atrial fibrillation risk, thyrotoxicosis, Machine Learning, risk scale, 
thyrotoxicosis complications, chronic disease. 
1 Introduction 
Thyrotoxicosis (TT) is associated with an increase in both total and cardiovascular mor-
tality. The majority of patients with TT are working-age individuals. Consequently, the 
negative social impact of TT remains incredibly significant [1]. Due to the risk of 
thromboembolic events and heart failure, one of the severest complications of TT is 
atrial fibrillation (AF). The thyrotoxic AF (TAF) incidence is as follows: 7–8% among 
middle-aged patients, 10–20% in seniors and 20–35% for those having ischemic heart 
disease or valvular disease  [2–5]. High incidence, severity and also a significant ad-
verse impact on life quality – all these facts make TAF prevention a crucial problem. 
Regrettably, there is no established TAF risk calculation scale at the moment. Never-
theless, devising one would allow selecting patients with a high risk of TAF for the 
closest follow-up or for early radical treatment of TT – surgical or radioiodine therapy 
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instead of long-term medical treatment. This will ultimately lead to a decrease in TAF 
frequency. 
2 Existing methods overview 
In the literature, the topic of assessing the risk of AF development is described in suf-
ficient detail. There are several approaches to solving this problem. In the first ap-
proach, the authors study risk factors for atrial fibrillation, predicting the probability of 
AF development for a specific period using regression analysis. For example, the 10-
year risk of AF development is estimated[1]; multivariate Cox regression is used as 
tools. The results obtained with this approach are quite reliable, but such models do not 
include many factors that presumably affect the risk of AF. Also, these models do not 
take into account the specifics of AF development in patients with certain chronic dis-
eases (in contrast to the models of the second approach). In the second approach, the 
risk of AF is estimated for patients with a certain chronic disease, such as diabetes[5], 
and it is revealed that patients with diabetes have a 49% higher risk of developing AF. 
In the third approach, meta-studies of populations are conducted to analyze the risk 
factors for AF, for example[6]. In this article, the authors described a cross-sectional 
study of California residents. Those results are interesting and can be used to calibrate 
the models obtained by MO methods; however, within using these works we cannot 
assess the probability of AF development in a particular person. Many factors can in-
fluence the probability of AF.  It is necessary to consider both the specifics of this 
complication and the specifics of a chronic disease when we create a model for as-
sessing the risk of AF. Therefore, special methods are needed for creating such a model. 
This study presents an approach to the estimator's risk of atrial fibrillation for patients 
who suffer from thyrotoxicosis. This approach considers the specifics of the influence 
of the thyrotoxicosis course for a particular patient on the probability of AF. 
To date, a lot of data have been obtained about thyrotoxic atrial fibrillation risk fac-
tors. The majority of investigations have demonstrated that the most significant predic-
tors of this severe arrhythmia are advancing age, male gender, prolonged thyrotoxicosis 
duration, high level of thyroid hormones and concomitant cardiovascular diseases[2, 
7–11]. Findings from other researches have shown that factors like female gender, obe-
sity, heart rate more than 80 beats per minute, the presence of left ventricular hypertro-
phy, big left atrium diameter, chronic renal disease and proteinuria, elevated liver trans-
aminase and C-reactive protein levels predispose to thyrotoxic atrial fibrillation[12–
14]. Thus, based on the comprehensive literature review, we can conclude that available 
data on thyrotoxic atrial fibrillation predictors are contradictory and, furthermore, a lot 
of studies have an insufficient evidence base. Moreover, for an individual’s absolute 
risk evaluation, integrating multiple risk factors and identify the most significant of 
them, are required. Accordingly, it is necessary to develop a system for ranking risk 
factors by their degree of impact and models for calculating the risk of thyrotoxic AF. 
Using the system for ranking we need to create an easy-to-use and interpretable model 
for assessing the risk of developing atrial fibrillation in patients with thyrotoxicosis. All 
of the above explain relevance of this study. 
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3 Case study 
3.1 Data 
The study included 420 patients with a history of overt thyrotoxicosis. The study sam-
ple was divided into two subgroups: one includes 127 (30.2%) individuals with thyro-
toxic atrial fibrillation and other - 293 (69.8%) patients without. All participants were 
treated previously or at the time of the study for thyrotoxicosis in Almazov National 
Medical Research Centre or in Pavlov First Saint Petersburg State Medical University, 
St. Petersburg, Russia in 2000-2019. 
Entry criteria: 
• Men and women with overt thyrotoxicosis, associated with Graves’ disease, 
toxic adenoma or multinodular toxic goiter. 
• Age between 18 and 80 years. 
Exclusionary criteria: 
• Subclinical hyperthyroidism. 
• A history of atrial fibrillation developed before the onset of thyrotoxicosis. 
• Concomitant diseases that may affect structure and function of the cardiovas-
cular system: hemodynamically significant valve disease, nonthyrotoxic car-
diomyopathy, severe obstructive lung diseases. 
• Chronic intoxication (alcohol, toxicomania). 
• Pregnancy at the time of thyrotoxicosis. 
The data includes 4 groups of features (abbreviations are indicated in brackets): 
• Physiological: gender, age, height, weight, body mass index (BMI), the gene-
sis of thyrotoxicosis «Genesis of TT», smoking status «SC», total cholesterol 
«TC», triglycerides «TG», low density lipoprotein cholesterol «LDL» level 
high density lipoprotein cholesterol «HDL», creatinine «CR», potassium «K» 
and hemoglobin «HB» levels during TT. 
• Initial cardiological status before the development of TT: arterial hypertension 
«AH before TT», coronary heart disease before TT «CHD before TT», various 
heart rhythm disorders before TT «HRD before TT», congestive heart failure 
«CHF before TT», heart rate reducing therapy antiarrhythmic drugs, ivabra-
dine, beta-blockers, and other types of therapy «HRRT before TT».  
• Characteristics of thyrotoxicosis: free tetraiodothyronine «FT4», triiodothyro-
nine «FT3», thyroid-stimulating hormone receptor antibodies level 
«TSHRA», duration of TT, for patients with AF - duration of TT before AF 
«DTT», subclinical TT duration (more less than 12 months) «DSTT», the 
number of relapses of TT «RTT», the presence of episodes of hypothyroidism 
«EHT», therapy of thyrotoxicosis «TTT», the duration of thyrostatic therapy 
«DTST», the time after TT onset when thyroidectomy or radioiodine therapy 
was provided «TTRTP». 
• Cardiological status during the TT: arterial hypertension «AH during the TT», 
heart rate during the first examination «HR during the TT» and maximum rec-
orded during TT heart rate «MHR during the TT», supraventricular extrasys-
tole «SVE during the TT», ventricular extrasystole «VE during the TT», other 
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heart rhythm disorders  «OHRD heart rhythm disorders», congestive heart 
failure «CHF during the TT», heart rate reducing therapy «HRRT during the 
TT». 
3.2 Models creation 
The main objective of the study is to create a practical method for assessing the risk of 
developing atrial fibrillation in a patient with thyrotoxicosis. The model should include 
both features unique to the disease and physiological parameters. 
At the initial stage, we have a table with observations(rows) and features(columns). 
The preprocessing of this dataset included five-stage. This stage shows in figure 1. 
 
Fig. 1. Preprocessing stages 
In the first stage, we deleted observations that include a large number of omissions.  
In the second stage of preprocessing we replace gaps among the values. In the third 
stage, we calculated quantiles for each discrete feature. Next, we divided the values of 
all discrete features into three intervals. We use quantiles as intervals threshold. Using 
the B3 method, we first use the A1 method. Then we use One-Hot-Encoder methods 
for coding categorical values. On the fourth stage, we tested each featured couple on 
collinearity. On the next stage, we selected features for each dataset.  
Finally, we created 180 different datasets (2*2*3*2*5). Each dataset contains a 
unique sequence of processing and selecting variables for prediction. 
Next, the sample was divided into test and training, classes were balanced by pre-
sampling features. The model was selected from the models KNeighborsClassifier, 
RandomForestClassifier, LogisticRegression, DecisionTreeClassifier, XGBClassifier, 
SVC, GaussianNB, MultinomialNB, BernoulliNB. For each model, metrics f1, accu-
racy, recall, precision for cross-validation were calculated for each of the datasets. Ta-
ble 1 is a fragment of a table with the results of cross-validation. 
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Table 1. Models comparison 
Model Accuracy 
averege 
F1  
averege 
Recall 
averege 
Precision 
averege 
Preprocessing 
XGB 0.876 0.793 0.788 0.801 B1 A2 C3 B4 B5 
BernoulliNB 0.834 0.742 0.788 0.701 A1 C2 B3 B4 A5 
GaussianNB 0.819 0.73 0.8 0.677 B1 C2 B3 B4 C5 
LR 0.835 0.726 0.715 0.742 A1 C2 B3 B4 B5 
DecisionTree 0.806 0.703 0.675 0.666 B1 A2 A3 B4 B5 
RandomForest 0.819  0.687 0.609 0.753 С1 B2 B3 A4 C5 
MultinomialNB 0.777 0.653 0.693 0.618 A1 C2 B3 B4 C5 
KNeighbors 0.796 0.614 0.537 0.720 A1 C2 B3 A4 B5 
SVC 0.765 0.452 0.327 0.778 A1 C2 B3 B4 D5 
This table includes the best combination of dataset preprocessing steps and model 
type for each model. The table is ranked by the f1 average. The best result was shown 
by the XGBClassifier model - 0.79 f1 average, 0.88 accuracies, and 0.8 precision. The 
method of processing the dataset is to remove features with more than 50% gaps, close 
gaps with averages, do not encode variables with naive coding and do not use quantiles, 
do not delete collinear features, the threshold for selecting functions is 0.9. Given the 
initial balance of classes 3 to 7 with a given quality, it makes sense to apply this model 
in practice. In terms of recall, the best result was shown by the GaussianNB model - 
0.8. For reasons of interpretability, it is also advisable to use the DecisionTreeClassifier 
model (0.81 accuracies and 0.70 f1). Also, a good result was shown by the LR model 
(0.835 accuracies). This model has high interpretability. Also, for the convenience of 
using this model, it can be translated into a simple scale. To each attribute to associate 
a certain score. Given the high sensitivity and specificity, it also makes sense to use it 
in practice.  
The main study objective is the creation of a set of models convenient for their ap-
plication in practice. Today, there are many predictive models, but fewer of them are 
applied in practice. This is due to many factors. For example, the reluctance of doctors 
to work with the new software on which the model is based. Or the model has high 
accuracy, but it is not clear how to interpret the results. The decision-making system in 
the form of a scale is understandable and convenient for medical specialists. Each factor 
has a specific score. This score indicates the contribution of the factor to prognosis. 
Scales are widespread in medical practice, for example, the FINDRISK scale [15]. 
On base Logistic Regression model, we can create a scale for estimated atrial fibril-
lation risk. The preprocessing process is shown in figure 1. Out of 176 signs, the model 
showed the best quality at 60. The grid search method found model parameters. 
The features were awarded points based on the regression coefficient. If the absolute 
value of the regression coefficient lay in the half-interval (0.0.5] - 0.5 points, (0.5.1] -1 
point, (1.2] - 2 points, (2.3] - 3 points, (3.4] - 4 points.  
The following values most significantly reduce the risk of atrial fibrillation: supra-
ventricular extrasystole, which appeared against the background of thyrotoxicosis, du-
ration of thyrotoxicosis is less than 6 months (coefficient -4); atrial pacemaker 
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migration, Infiltrative ophthalmopathy and pretibial myxedema, duration of thyrotoxi-
cosis of more than 6 and less than 12 months (coefficient -3); lack of arterial hyperten-
sion in the presence of thyrotoxicosis, presence of hypertension with target blood pres-
sure values during treatment, hemoglobin more than 120 g / l and less than 132 (coef-
ficient -2). 
The most significant increase in the risk of Atrial Fibrillation is as follows: Diabetes 
mellitus (+4 coefficient); Heart rate on the background of TT is greater than 89 and less 
than 95 (coefficient 3); thyroidectomy thyrostatic therapy of thyrotoxicosis, male, lack 
of pulse-reducing therapy against thyrotoxicosis, impaired glucose tolerance, ventricu-
lar extrasystole, which appeared against the background of thyrotoxicosis, duration of 
tirputeostatic therapy, months> 40.0, time of radical treatment (how many years after 
the debut thyrotoxicosis performed thyroidectomy or radioiodine therapy, months) less 
than 77(+2 coefficient). 
The developed scale was designed in the form of a questionnaire, which allows, 
without medical tests, to assess the risk of developing Atrial Fibrillation for a particular 
patient. You can see a fragment of this questionnaire in Figure 2. 
 
Fig. 2. Fragment of AF risk questionnaire 
The final score was calculated for each patient, patients were divided into 4 risk 
groups.  Table 2 shows the incidence of AF. Groups 2 and 3 include the most severe 
patients, the indicator of getting into this group shows very high values of sensitivity 
and specificity. This table shows the accuracy of the created scale. This scale is a 
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standard scale for assessing the risk of complication, created using the same tools as 
the well-known FINDRISK scale [15] and was validated similarly[16, 17]. 
Table 2. Risk scale metrics for the development of AF. 
Risk level frequency_FP0 frequency_FP1 Score 
Low 1 0 <=-5 
Average 0.454545 0.545455 (-5,1] 
Tall 0.0980392 0.901961 (1,5.5] 
Very tall 0.0526316 0.947368 >=5.5 
3.3 Results analysis 
In figures 3 and 4, we visualized the 1st tree in gradient boosting. 
 
Fig. 3. Fragment of decisions tree for patients with supraventricular extrasystole 
Figure 3 we visualized a fragment of decision tree for patients with supraventricular 
extrasystole. Presumably, the most important symptom is the presence of supraventric-
ular extrasystole in the patient. Also, this decision tree confirms the a priori significance 
of the signs describing the specificity of the course of thyroid disease in a particular 
patient. Presumably, the longer the duration of thyrotoxicosis, the higher the probability 
of AF. The age and heart rate detected at the first examination also increase the proba-
bility of atrial fibrillation in patients with thyrotoxicosis and supraventricular extrasys-
tole. 
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Fig. 4. Fragment of decisions tree for patients with supraventricular extrasystole 
Figure 4 we visualized a fragment of decision tree for patients without supraventric-
ular extrasystole. From the first tree, it follows that the most important criterion for the 
presence of AF is age. However, the specifics of constructing trees in gradient boosting 
does not always allow us to determine the importance of a particular trait for a predicted 
variable. We try to analyze the decision tree created on the basis of the Desission-
TreeClassifier model. Visualization of 2 fragments of this tree is presented in figures 5 
and 6. 
Figure 5 describes the branch for patients who do not have supraventricular extra-
systole.  Based on the tree structure, supraventricular extrasystole is one of the most 
important signs that contribute to the probability of AF. The absence of supraventricular 
extrasystole with an 89% probability means that AF will not develop in this patient. 
Further, patients are divided by age, threshold 58.5. Age above 58 indicates a high 
probability of developing AF if in these patients the FDT3 level exceeds 1.6. For pa-
tients younger than 58 without extrasystole, the probability of developing AF is high 
only if thyrostatic therapy duration is above 225 or the duration of thyrotoxicosis is 
above 65 months. The risk of developing thyrotoxicosis is also affected by body mass 
index (the higher the variable, the higher the risk of AF) and pulse therapy. If therapy 
was carried out, the risk of atrial fibrillation is significantly higher than in the absence 
of therapy.  
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Fig. 5. Fragment of decisions tree for patients without supraventricular extrasystole 
 
Fig. 6. Fragment of decisions tree for patients with supraventricular extrasystole 
We analyzed the second fragment - the course of the disease for patients with supra-
ventricular extrasystole. For this group of patients, obesity of the 2nd and 3rd degrees 
10 
indicates a high probability of A even in the absence of problems with carbohydrate 
metabolism. If the patient does not have obesity, does not have a violation of carbohy-
drate metabolism, and does not undergo heart rate reducing therapy, the probability of 
AF is close to 0. If there are problems with MA without analyzing other factors, the 
patient has a 60% chance of developing AF. Further risk assessment depends on age 
(the younger the patient, the lower the risk), potassium level, FT3, the presence of other 
heart rhythm disturbances, FT3 and the duration of hypertension. These findings are 
confirmed by a priori knowledge and expert opinion of doctors. This decision tree is a 
fairly simple and well-interpreted method that can be useful as part of a support and 
decision-making system for medical professionals working with patients with thyro-
toxicosis. Similarly, the complete structure of the tree was analyzed. The findings were 
interpreted by experts in the field of thyrotoxicosis. The knowledge gained about the 
relationship between the risk of AF and the specific course of thyrotoxicosis can be 
used to create a support and decision-making system. 
Confusion matrices were constructed and analyzed. In terms of f1, XGBoostClassi-
fier has the best predictive power. However, Logistic Regression has fewer false-nega-
tive errors. Given the balance of classes, DecisionTreeClassifier has good predictive 
power, despite the simplicity of the model (sensitivity 0.8 and specificity 0.63). Deci-
sionTreeClassifier is the most convenient model for interpretation. The choice of a spe-
cific model depends on the goals that the medical specialist wants to achieve. If it is 
more important to find all patients at risk of developing AF, XGBoost is better, because 
the model has the most specificity. If it is important to find all patients whose AF does 
not develop, then it is more logical to apply Logistic regression. For ease of use and 
interpretation of the result, it makes sense to use DecisionTreeClassifier or scale. 
4 Analysis atrial fibrillation paths in dynamic 
We analyzed at the way atrial fibrillation occurs. We used data from 1450 patients suf-
fering from thyrotoxicosis of any form. We divided the patient data into 2 groups. 
Group 1 includes 450 patients who have developed atrial fibrillation. Group 2 includes 
1000 patients in whom atrial fibrillation did not develop in the observed period. Next, 
we present the patient's course of diseases in the form of a pathway. We use graphs 
representation. The nodes were the codes of "mkb10" (international statistical classifi-
cation of diseases) with that the patient was admitted for treatment to the Almazov 
Medical Center. We created edges from an earlier node to a later node. In figures 7 and 
8 showed graphs for the two groups. The colors show the clusters. These clusters were 
obtained by the method of maximizing modularity. The size of the node depends on its 
degree.  
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Fig. 7. Pathways of thyrotoxicosis for 450 patients with atrial fibrillation 
This graph contains 211 nodes "mkb10" and 1035 edges. Largest nodes in terms of 
degree are observation for suspected other diseases or conditions (Z03.8, purple clus-
ter), congestive heart failure (I50.0, black cluster), past myocardial infarction ( I25.2 
purple cluster), other forms of angina pectoris (I20. 8, purple cluster), hypertension 
(I10, green cluster), atherosclerotic heart disease (I25.1, purple cluster), past myocar-
dial infarction (I25.1, orange cluster). A diagnosis of AF is associated with each of 
these conditions. Therefore, when one of these conditions occurs, the patient is at risk 
of atrial fibrillation. It is a signal for the use of the above models. We include all large 
nodes in the model features. 
Heart failure diagnosis is the center of gray clusters. This disease relates TT with 
another diagnosis in gray clusters. This cluster includes several types of anemia, heart 
disease, and limb disease. We assume that these diseases influence on risk AF only 
together with heart failure diagnosis. Observation with suspected other diseases or con-
ditions, other forms of angina pectoris, acute transmural infarction of the lower myo-
cardial wall, ventricular tachycardia are the largest nodes in the purple cluster. This 
cluster in heart disease clusters. All these diseases were included in model train fea-
tures. The pathways of AF for patients of 2 types of thyrotoxicosis are described in the 
green cluster. These species are thyrotoxicosis with diffuse goiter and thyrotoxicosis 
with toxic multinodular goiter. If patient suffers from these diseases, his risk-AF-
indicators include codes E66.0 (obviosity) I10 (diabetes mellitus), cardiomyopathies 
(I42.0,I42.8).  Therefore, for these patients group right diets is very important. Blue 
cluster included patients which other forms of thyrotoxicosis and thyrotoxicosis un-
specified. For patients in this pathway group, indicators of AF include hypertension, 
cerebral atherosclerosis. Since 2 types of atrial fibrillation belong to this cluster, pa-
tients from this group must be automatically spent in the risk group.  
The following types of atrial fibrillation fall into the blue cluster: Paroxysmal atrial 
fibrillation, typical atrial flutter. These forms of AF are most closely associated with a 
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diagnosis of E05.8 (unspecified forms of thyrotoxicosis), E05.9 (unspecified forms of 
thyrotoxicosis). All clusters were analyzed. And we identified indicators of increased 
risk for each particular type of Atrial Fibrillation. Those pieces of knowledge used in 
predictive models of atrial fibrillation. 
  
 
Fig. 8. Pathways of thyrotoxicosis for 1000 patients without atrial fibrillation 
Table 3. Graph Statistics. 
Statistic Graph for first group Graph for second group 
Average degree 4,52 5.355 
Graph diameter 10 9 
Graph density 0.009 0.014 
Сomponents 9 4 
The average length of the path 3.217 3.09 
Average clustering factor 0.308 0.33 
Based on table 3, the graph structure is different. The average degree is higher in the 
trajectories of patients without AF. This can be explained by different group sizes. The 
different structure of the course of thyrotoxicosis for these groups of patients follows 
from a different number of components. We can calculate the distance of similarity for 
a couple of particular pathways. Therefore, we propose new features - distance from 
particular pathways to pathways from these graphs. We think, when this feature is in-
cluded in the Machine Learning model, the quality of the predicted is improved. We 
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plan to study this hypothesis in future work. The obtained knowledge will be used in 
future work to create a dynamic model that predicts the risks of other complications. 
5 Conclusion and Future Work 
As a result of the study, we created a practical method for assessing the risk of AF. This 
method includes 4 models. The choice of a particular model by a medical specialist 
depends on the specific treatments-diagnostic goal. The best combination of specificity 
and completeness was shown by a model based on Gradient Boosting. This model takes 
into account both the specifics of the course of thyrotoxicosis in a particular patient and 
many other features that affect the risk of AF. Given the high-quality indicators of the 
constructed models, these models may be applicable for early prediction of atrial fibril-
lation in a patient. The development will allow medical staff to select patients with a 
high risk of TAF for immediate follow-up or for early radical treatment for TT - surgical 
treatment or treatment with radioactive iodine instead of long-term medical treatment. 
We create a scale for assessing the risk of developing Atrial Fibrillation. The main ad-
vantage of the scale is its ease of use and good interpretability. Medical staff can use 
this scale without special software. All constructed models simplify the process of 
working with patients suffering from thyrotoxicosis.  Further work includes improving 
the quality of the models used by increasing the data features and the use of neural 
networks, and analysis of atrial fibrillation pathways in dynamics using graphs. 
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